DCGI gives nod to India’s first indigenous mRNA vaccine for human trial
NEW DELHI: India’s first indigenous mRNA vaccine candidate has received approval from Indian Drug regulator Drug Controller General of India (DGCI) to initiate Phase I/II human clinical trial. The novel mRNA vaccine candidate, HGCO19 has been developed by Gennova, Pune and supported with seed grant under the Ind-CEPI mission of Department of Biotechnology of Ministry […]